This is a routine sell-to-cover transaction for tax withholding on vested equity awards, not a discretionary insider sale. Monitor for any subsequent Form 4 filings to confirm the sale was executed, but no material signal for the stock.
MIRM drugs
MIRM drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5- T+0 · Nov 5 $93.54entry
- T+1 · 11d ago +0.19%α −0.12% · $93.72
- T+5 · 5d ago −0.22%α −3.52% · $93.33
- T+7 · todayOpen
- T+20 · in 17d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Joanne Quan, a former officer of Mirum Pharmaceuticals, filed a Form 144 to sell 14,684 shares of common stock with an approximate value of $1.42 million. The filing indicates the sale is a sell-to-cover transaction for taxes owed related to recent vesting of stock unit awards. The sale represents a small fraction of the company's $5.6B market cap and appears routine in nature.
Key Facts
- Joanne Quan, a former officer, filed a Form 144 to sell 14,684 shares of Mirum common stock.
- The approximate market value of the proposed sale is $1,423,907.48.
- The filing states this is a sell-to-cover transaction for taxes owed related to recent vesting of stock unit awards.
- The shares were acquired on 11/02/2026 via vesting of restricted stock units under a registered plan.
- The proposed sale date is 11/04/2026, and the shares are listed on Nasdaq.
- The sale represents about 0.02% of the company's $5.6B market cap.
Financial Impact
Proposed sale of 14,684 shares valued at approximately $1.42 million, representing a small fraction of the company's market cap.
Risk Factors
- The sale may still be executed, but the disclosed purpose (tax withholding) reduces signaling value.
- No other insider selling patterns or context provided to assess broader insider sentiment.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001670138-26-000007 |
| Document: 0001670138-26-000007-index.html | 0001670138-26-000007 |
| Document: 0001670138-26-000007.txt | 0001670138-26-000007 |
Track record
27 reports on MIRM
5 of 5 bullish or bearish reports moved the stock their way by T+60. Best: +28.29% at T+20 after the Jun 11, 2026 report. 8 of 10 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $92.28 Now $91.58 −0.76% settles Feb 12
- Nov 13, 20263d ago Insider Cluster Neutral 3/10 Entry $93.54 Now $91.58 −2.10% settles Feb 12
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $93.33 Now $91.58 −1.88% settles Feb 10
- Nov 10, 20266d ago 8-K Bullish 6/10 Entry $94.42 Now $91.58 −3.01% settles Feb 8
- Nov 4, 202612d ago 144 Neutral 2/10 Viewing Entry $93.54 Now $91.58 −2.10% settles Feb 3
- Nov 4, 202612d ago 144 Neutral 2/10 Entry $93.54 Now $91.58 −2.10% settles Feb 3
- Nov 3, 202613d ago 8-K Bullish 6/10 Entry $96.97 Now $91.58 −5.56% settles Feb 2
- Oct 27, 202620d ago Institutional Cluster Mixed 4/10 Entry $85.81 Now $91.58 +6.72% settles Jan 26
- Oct 26, 202621d ago 8-K Bullish 6/10 Entry $85.56 Now $91.58 +7.04% settles Jan 25
- Oct 13, 20264w ago 8-K Bullish 7/10 Entry $79.62 Now $91.58 +15.02% settles Jan 8
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers